Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

NCT01407679 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Cutaneous

Interventions

DRUG: Alitretinoin

Sponsor

University Hospital Muenster

Collaborators

[object Object]